[1]JournalofMedicinalChemistry,1998,vol.41,p.4983-4994
[2]Patent:WO2017/161119,2017,A1.Locationinpatent:Page/Pagecolumn113
[3]CanadianJournalofResearch,SectionB:ChemicalSciences,1949,vol.27,p.291,295
[4]BioorganicandMedicinalChemistryLetters,2006,vol.16,p.905-910
[5]BioorganicandMedicinalChemistry,2009,vol.17,p.7850-7860
[6]BioorganicandMedicinalChemistryLetters,2011,vol.21,p.4255-4258
[7]Patent:WO2019/133770,2019,A2.Locationinpatent:Paragraph001341;001342;001343
[1]Patent:WO2017/161119,2017,A1.Locationinpatent:Page/Pagecolumn112-113
[1]CurrentPatentAssignee:GUANGZHOUHENOVCOMBIOSCIENCE-EP3401315,2018,A1Locationinpatent:Paragraph0148;0151
Title: Identification of (3R)-7-hydroxy-N-((1S)-1-[[(3R,4R)-4-(3-hydroxyphenyl)- 3,4-dimethyl-1-piperidinyl]methyl]-2-methylpropyl)-1,2,3,4-tetrahydro- 3-isoquinolinecarboxamide as a novel potent and selective opioid kappa receptor antagonist.
Journal: Journal of medicinal chemistry 20030703